Literature DB >> 30220452

Ovarian masses in the child and adolescent: An American Pediatric Surgical Association Outcomes and Evidence-Based Practice Committee systematic review.

Elizabeth J Renaud1, Stig Sømme2, Saleem Islam3, Danielle B Cameron4, Robert L Gates5, Regan F Williams5, Tim Jancelewicz5, Tolulope A Oyetunji6, Julia Grabowski7, Karen A Diefenbach8, Robert Baird9, Meghan A Arnold10, Dave R Lal11, Julia Shelton12, Yigit S Guner13, Ankush Gosain14, Akemi L Kawaguchi15, Robert L Ricca16, Adam B Goldin17, Roshni Dasgupta18.   

Abstract

BACKGROUND: The treatment of ovarian masses in pediatric patients should balance appropriate surgical management with the preservation of future reproductive capability. Preoperative estimation of malignant potential is essential to planning an optimal surgical strategy.
METHODS: The American Pediatric Surgical Association Outcomes and Evidence-Based Practice Committee drafted three consensus-based questions regarding the evaluation and treatment of ovarian masses in pediatric patients. A search of PubMed, the Cochrane Library, and Web of Science was performed and Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed to identify articles for review.
RESULTS: Preoperative tumor markers, ultrasound malignancy indices, and the presence or absence of the ovarian crescent sign on imaging can help estimate malignant potential prior to surgical resection. Frozen section also plays a role in operative strategy. Surgical staging is useful for directing chemotherapy and for prognostication. Both unilateral oophorectomy and cystectomy have been used successfully for germ cell and borderline ovarian tumors, although cystectomy may be associated with higher rates of local recurrence.
CONCLUSIONS: Malignant potential of ovarian masses can be estimated preoperatively, and fertility-sparing techniques may be appropriate depending on the type of tumor. This review provides recommendations based on a critical evaluation of recent literature. TYPE OF STUDY: Systematic review of level 1-4 studies. LEVEL OF EVIDENCE: Level 1-4 (mainly 3-4).
Copyright © 2018. Published by Elsevier Inc.

Entities:  

Keywords:  Adolescent; Diagnosis; Management; Ovarian mass; Pediatric

Mesh:

Year:  2018        PMID: 30220452     DOI: 10.1016/j.jpedsurg.2018.08.058

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  10 in total

1.  Long-term surgical outcomes in pediatric ovarian neoplasms: 20-year single-center experience.

Authors:  Bade Toker Kurtmen; Zafer Dokumcu; Emre Divarci; Orkan Ergun; Geylani Ozok; Ahmet Celik
Journal:  Pediatr Surg Int       Date:  2022-09-28       Impact factor: 2.003

2.  International Society of Paediatric Surgical Oncology (IPSO) Surgical Practice Guidelines.

Authors:  Simone de Campos Vieira Abib; Chan Hon Chui; Sharon Cox; Abdelhafeez H Abdelhafeez; Israel Fernandez-Pineda; Ahmed Elgendy; Jonathan Karpelowsky; Pablo Lobos; Marc Wijnen; Jörg Fuchs; Andrea Hayes; Justin T Gerstle
Journal:  Ecancermedicalscience       Date:  2022-02-17

3.  Understanding the Value of Tumor Markers in Pediatric Ovarian Neoplasms.

Authors:  Amy E Lawrence; Mary E Fallat; Geri Hewitt; Paige Hertweck; Amanda Onwuka; Amin Afrazi; Christina Bence; Robert C Burns; Kristine S Corkum; Patrick A Dillon; Peter F Ehrlich; Jason D Fraser; Dani O Gonzalez; Julia E Grabowski; Rashmi Kabre; Dave R Lal; Matthew P Landman; Charles M Leys; Grace Z Mak; R Elliott Overman; Brooks L Rademacher; Manish T Raiji; Thomas T Sato; Madeline Scannell; Joseph A Sujka; Tiffany Wright; Peter C Minneci; Katherine J Deans; Jennifer H Aldrink
Journal:  J Pediatr Surg       Date:  2019-10-25       Impact factor: 2.545

Review 4.  Ovarian neoplasms of childhood.

Authors:  Shailee V Lala; Naomi Strubel
Journal:  Pediatr Radiol       Date:  2019-10-16

5.  The diagnostic value of magnetic resonance imaging in differentiating benign and malignant pediatric ovarian tumors.

Authors:  Carlijn L Janssen; Annemieke S Littooij; Marta Fiocco; Josephine C B Huige; Ronald R de Krijger; Caroline C C Hulsker; Angelique J Goverde; József Zsiros; Annelies M C Mavinkurve-Groothuis
Journal:  Pediatr Radiol       Date:  2020-11-13

6.  Neuroendocrine Tumors: Clinical, Histological and Immunohistochemical Perspectives and Case Report-Mature Teratoma in a 16-Year-Old Girl.

Authors:  Elżbieta Sowińska-Przepiera; Dariusz Starzyński; Anhelli Syrenicz; Ireneusz Dziuba; Barbara Wiszniewska; Sylwia Rzeszotek
Journal:  Pathophysiology       Date:  2021-08-27

7.  Early stage ovarian immature teratoma, surveillance or chemotherapy after surgery? A propensity score matched analysis.

Authors:  Xinyue Zhang; Jie Yang; Jinhui Wang; Ying Zhang; Jiaxin Yang
Journal:  Gynecol Oncol Rep       Date:  2022-04-04

8.  Ovarian neoplasia in adolescence: a retrospective chart review of girls with neoplastic ovarian tumors in Saudi Arabia.

Authors:  Lateefa AlDakhil; Asma Aljuhaimi; Mashael AlKhattabi; Saleh Alobaid; Rafif E Mattar; Abdulaziz Alobaid
Journal:  J Ovarian Res       Date:  2022-09-16       Impact factor: 5.506

9.  What Should Be the Topics of a Prospective Study on Ovarian Masses in Children?-Results of a Multicenter Retrospective Study and a Scoping Literature Review.

Authors:  Justyna Łuczak; Maciej Bagłaj; Piotr Dryjański; Alicja Kalcowska; Nastazja Banaszyk-Pucała; Maria Boczar; Krzysztof Dymek; Małgorzata Fryczek; Kaja Giżewska-Kacprzak; Wojciech Górecki; Andrzej Grabowski; Anna Gregor; Maria Jabłońska; Grzegorz Kowalewski; Magdalena Lewandowska; Maria Małowiecka; Anna Ogorzałek; Magdalena Pękalska; Aneta Piotrowska-Gall; Mateusz Porębski; Marek Siewiński; Dariusz Patkowski
Journal:  Curr Oncol       Date:  2022-02-28       Impact factor: 3.677

10.  Ultrasonographic diagnosis and surgical outcomes of adnexal masses in children and adolescents.

Authors:  Gun Gu Kang; Kyeong A So; Ji Young Hwang; Nae Ri Kim; Eun Jung Yang; Seung Hyuk Shim; Sun Joo Lee; Tae Jin Kim
Journal:  Sci Rep       Date:  2022-03-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.